Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 13, 2024
- Accession no.
- 0001773751-24-000008
- Filed
- Feb 13, 2024
- Trade date
- Feb 9-12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $399.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | Class A Common Stock | SSaleDisposed | −8,509 | $10.03F2 | −$85,345.27 | 161,699 | Direct | |
| Feb 12, 2024 | Class A Common Stock | MOption exerciseAcquired | +26,385 | $5.01 | +$132,188.85 | 188,084 | Direct | |
| Feb 12, 2024 | Class A Common Stock | SSaleDisposed | −31,363 | $10.03F3 | −$314,570.89 | 156,721 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Class A Common Stock | MOption exerciseDisposed | −26,385 | $0.00 | $0 | 1,004,922 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.01 - $10.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.09. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.